Guiyang Xintian Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Guiyang Xintian Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and distribution of proprietary Chinese medicines. The company focuses primarily on gynecological health, urology, and other therapeutic areas. Its core product portfolio includes Kuntai Capsules, used for treating menopausal syndrome; Ningmitai Capsules, indicated for urinary tract infections; and Bitongxiao Granules, used for breast hyperplasia. The firm emphasizes the modernization of Traditional Chinese Medicine (TCM) through rigorous scientific research and standardized production processes. By integrating traditional formulas with modern pharmaceutical technology, the company aims to provide clinical solutions for chronic and common diseases. Its operations encompass the entire value chain from raw material sourcing to clinical application, maintaining a strong presence in the clinical market through a professional academic promotion model.